138 related articles for article (PubMed ID: 15006109)
1. Self-sampling in screening to reduce mortality from colorectal cancer: a qualitative exploration of the decision to complete a faecal occult blood test (FOBT).
O'Sullivan I; Orbell S
J Med Screen; 2004; 11(1):16-22. PubMed ID: 15006109
[TBL] [Abstract][Full Text] [Related]
2. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
3. Different faecal sampling methods alter the acceptability of faecal occult blood testing: a cross sectional community survey.
Ellis RJ; Wilson S; Holder RL; McManus RJ
Eur J Cancer; 2007 Jun; 43(9):1437-44. PubMed ID: 17475476
[TBL] [Abstract][Full Text] [Related]
4. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT.
Clavarino AM; Janda M; Hughes KL; Del Mar C; Tong S; Stanton WR; Aitken JF; Leggett BA; Newman B
Prev Med; 2004 Sep; 39(3):482-90. PubMed ID: 15313087
[TBL] [Abstract][Full Text] [Related]
5. Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance.
Ore L; Hagoel L; Lavi I; Rennert G
Eur J Cancer Prev; 2001 Jun; 10(3):251-6. PubMed ID: 11432712
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
Damery S; Clifford S; Wilson S
BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
[TBL] [Abstract][Full Text] [Related]
7. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
[TBL] [Abstract][Full Text] [Related]
8. "It's a small price to pay for life": faecal occult blood test (FOBT) screening for colorectal cancer, perceived barriers and facilitators.
Reeder AI
N Z Med J; 2011 Mar; 124(1331):11-7. PubMed ID: 21725408
[TBL] [Abstract][Full Text] [Related]
9. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
10. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
Tong S; Hughes K; Oldenburg B; Del Mar C
Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
[TBL] [Abstract][Full Text] [Related]
11. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
12. Attitudes towards and beliefs about colorectal cancer and screening using the faecal occult blood test within the Italian-Australian community.
Severino G; Wilson C; Turnbull D; Duncan A; Gregory T
Asian Pac J Cancer Prev; 2009; 10(3):387-94. PubMed ID: 19640179
[TBL] [Abstract][Full Text] [Related]
13. Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust.
Chambers JA; Callander AS; Grangeret R; O'Carroll RE
BMC Cancer; 2016 Feb; 16():96. PubMed ID: 26872450
[TBL] [Abstract][Full Text] [Related]
14. Understanding of a negative bowel screening result and potential impact on future symptom appraisal and help-seeking behaviour: a focus group study.
Barnett KN; Weller D; Smith S; Orbell S; Vedsted P; Steele RJC; Melia JW; Moss SM; Patnick J; Campbell C
Health Expect; 2017 Aug; 20(4):584-592. PubMed ID: 27414462
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
16. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
17. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
Musil D; Tillich J
Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
[TBL] [Abstract][Full Text] [Related]
18. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
[TBL] [Abstract][Full Text] [Related]
19. What is the role of family in promoting faecal occult blood test screening? Exploring physician, average-risk individual, and family perceptions.
Lobchuk MM; Bapuji SB; McClement SE; Sisler JJ; Katz A; Martens P; Turner D; Clouston K
Cancer Epidemiol; 2012 Jun; 36(3):e190-9. PubMed ID: 22310235
[TBL] [Abstract][Full Text] [Related]
20. A case-control study to evaluate efficacy of screening for faecal occult blood.
Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
